(Total Views: 571)
Posted On: 03/26/2022 11:46:06 AM
Post# of 154882
Re: Goosebumps #120713
Goosebumps,
Have there been other companies that received BTD on phase two trials for NASH.
I may have mis-interpreted your post. I didn’t think actual liver biopsies occur until phase three trials?
Can anyone confirm?
If so, and other companies received BTD I would have to believe CYDY could as well.
This is where a partnership would plan a vital role to help finance phase three. Considering the time, biopsies etc it can be quite costly.
BTD would probably be required for BP to even want to partner. But given the prior comments by NP and SK I believe something is occurring. Especially since 350mg results met their endpoints. Possibly waiting for the 60 day window for reply from the FDA?
All speculation but a real possibility.
Please see the link: https://www.biospace.com/article/inventiva-s-...-for-nash/
Have there been other companies that received BTD on phase two trials for NASH.
I may have mis-interpreted your post. I didn’t think actual liver biopsies occur until phase three trials?
Can anyone confirm?
If so, and other companies received BTD I would have to believe CYDY could as well.
This is where a partnership would plan a vital role to help finance phase three. Considering the time, biopsies etc it can be quite costly.
BTD would probably be required for BP to even want to partner. But given the prior comments by NP and SK I believe something is occurring. Especially since 350mg results met their endpoints. Possibly waiting for the 60 day window for reply from the FDA?
All speculation but a real possibility.
Please see the link: https://www.biospace.com/article/inventiva-s-...-for-nash/
(2)
(0)
